When Wendy Wing-lok Chan's research team looked at more than 1,200 advanced cancer patients in Hong Kong, they discovered something quietly powerful: a smartphone app that asks patients just one simple question each week could transform how people face their final chapters.

The SUPPORT+ app represents a small but meaningful shift in how medicine approaches advanced cancer care. For patients no longer pursuing active cancer treatment, the burden of reporting symptoms often falls entirely on them — and many suffer in silence, enduring pain, fatigue, and sleep disturbance without reaching out for help. This app flips that script. Each week, patients complete a brief self-assessment about their physical and emotional symptoms. If they report mild or moderate symptoms, the app provides practical guidance for managing them. Anything more serious triggers an immediate response: a nurse from the palliative care team calls them personally to provide support.

The results speak for themselves. After 18 weeks, only about 12% of patients using the app experienced a decline in their functional abilities, compared with more than 17% in the usual-care group who had to report symptoms themselves. Even more striking, overall quality-of-life scores actually improved for app users while declining for those receiving standard care. The app users also had fewer hospital admissions and shorter stays when they did need to go to the hospital, though emergency room visits were similar between groups.

The study, conducted across six palliative care clinics in Hong Kong and led by Dr. Chan, a clinical associate professor of oncology at the University of Hong Kong, involved roughly half the participants using SUPPORT+ and half receiving conventional care. The research was presented at the American Society for Clinical Oncology annual meeting in Chicago and published in JAMA Network Open on June 1.

Dr. Toby Christopher Campbell, a thoracic medical oncologist at the University of Wisconsin who reviewed the findings, highlighted why this matters: "People with cancer frequently suffer from symptoms such as pain, fatigue or sleep disturbance and often bear those symptoms silently. When patients are able to report symptoms and receive help, they feel better, and that can lead to better outcomes." He noted that the trial adds crucial evidence that with proper symptom monitoring and timely interventions, patients can meaningfully improve both symptoms and quality of life.

The implications extend beyond Hong Kong. As health systems worldwide grapple with how to support aging populations and those managing serious illnesses, digital tools that bridge the gap between clinic visits offer a scalable solution. The beauty of SUPPORT+ lies in its simplicity: it doesn't require patients to advocate loudly for themselves or wait for appointments to voice struggles. Instead, it creates a gentle, proactive system where someone is always listening.

That said, the approach isn't without limitations. As Dr. Campbell pointed out, patients need sufficient digital literacy to use an app and follow instructions — a barrier that will vary by community and age. Still, for those who can access it, SUPPORT+ demonstrates that technology, paired with human compassion, can help people facing advanced cancer maintain not just survival, but dignity and quality in the time they have left.